# David M. Hyman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-m-hyman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 48,725 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 87 |
| i10-index | 220 |
| Last Known Institution | Jacksonville College |
| OpenAlex ID | https://openalex.org/A5068193017 |
| ORCID iD | https://orcid.org/0000-0001-8150-9762 |
| Works | 797 |

## Researcher papers

Showing 12 of 14.

- [Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients](https://scholariq.org/papers/mutational-landscape-of-metastatic-cancer-revealed-from-prospective-clinical/)
- [Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children](https://scholariq.org/papers/efficacy-of-larotrectinib-in-i-trk-i-fusion-positive-cancers-in-adults-and/)
- [OncoKB: A Precision Oncology Knowledge Base](https://scholariq.org/papers/oncokb-a-precision-oncology-knowledge-base/)
- [AACR Project GENIE: Powering Precision Medicine through an International Consortium](https://scholariq.org/papers/aacr-project-genie-powering-precision-medicine-through-an-international/)
- [Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy](https://scholariq.org/papers/patient-hla-class-i-genotype-influences-cancer-response-to-checkpoint-blockade/)
- [The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers](https://scholariq.org/papers/the-genomic-landscape-of-endocrine-resistant-advanced-breast-cancers/)
- [Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials](https://scholariq.org/papers/larotrectinib-in-patients-with-trk-fusion-positive-solid-tumours-a-pooled/)
- [Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes](https://scholariq.org/papers/therapy-related-clonal-hematopoiesis-in-patients-with-non-hematologic-cancers-is/)
- [High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants](https://scholariq.org/papers/high-intensity-sequencing-reveals-the-sources-of-plasma-circulating-cell-free/)
- [Cancer therapy shapes the fitness landscape of clonal hematopoiesis](https://scholariq.org/papers/cancer-therapy-shapes-the-fitness-landscape-of-clonal-hematopoiesis/)
- [Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies](https://scholariq.org/papers/prospective-comprehensive-molecular-characterization-of-lung-adenocarcinomas-for/)
- [Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing](https://scholariq.org/papers/mutation-detection-in-patients-with-advanced-cancer-by-universal-sequencing-of/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [Jacksonville College](https://scholariq.org/institutions/jacksonville-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.